Related Experiment Video

Updated: Aug 4, 2026

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

Short course chemotherapy for childhood tuberculosis

J Biddulph1

  • 1Department of Child Health, University of Papua New Guinea, Medical Faculty, Boroko.

The Pediatric Infectious Disease Journal
|November 1, 1990
PubMed

Insights

Short-course chemotherapy (SCC) is a safe and effective treatment for childhood tuberculosis (TB), including extrapulmonary forms. This study found SCC to be well-tolerated and successful in a prospective cohort of pediatric TB patients.

Area of Science:

  • Pediatric Infectious Diseases
  • Public Health
  • Pharmacology

Background:

  • Limited published data existed on the efficacy of short-course chemotherapy (SCC) for childhood tuberculosis (TB).
  • Childhood TB presents unique challenges in diagnosis and treatment adherence.
  • Extrapulmonary TB is common in young children.

Purpose of the Study:

  • To evaluate the safety and effectiveness of a 6-month SCC regimen in children with TB.
  • To assess clinical response and adverse drug reactions to SCC in a pediatric population.
  • To determine relapse rates and factors influencing treatment outcomes in childhood TB.

Main Methods:

  • A prospective study conducted in Port Moresby included all children diagnosed with TB between November 1984 and November 1986.
  • Children received a 6-month SCC regimen: 2 months daily rifampin, isoniazid, pyrazinamide, and streptomycin, followed by 4 months of twice-weekly rifampin and isoniazid.
  • Follow-up included clinical assessment and attempted 24-month post-treatment monitoring.

Main Results:

  • A rapid clinical response to SCC was observed in most children.
  • Adverse drug reactions were infrequent (2%), primarily associated with streptomycin.
  • Relapse occurred in 7 out of 373 children (1.9%), predominantly in those with irregular treatment adherence.

Conclusions:

  • Short-course chemotherapy (SCC) is a safe and effective treatment option for both pulmonary and extrapulmonary tuberculosis in children.
  • The SCC regimen demonstrated good tolerability and a low relapse rate in this cohort.
  • Adherence to treatment is crucial for successful outcomes in childhood TB management.

More Related Videos

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

Identification of Potential Anti-TB Candidates: A Step-by-Step Guide to Synthesis, MIC Determination, and Cytotoxicity Assessment in Mammalian Cells10:24

Identification of Potential Anti-TB Candidates: A Step-by-Step Guide to Synthesis, MIC Determination, and Cytotoxicity Assessment in Mammalian Cells

Published on: May 22, 2026

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...